Boyden Executive Search

Healthcare & Life Sciences

We work with the medical community to transform the lives of patients through the best scientific, management and leadership talent worldwide.

Subsectors

OTC drug makers, private research institutes, device manufacturers and others across the life science spectrum benefit from Boyden’s specialised expertise in meeting distinct talent needs.

Trevor M. Pritchard

Partner, United States
North America Leader, Healthcare & Life Sciences Practice

Articles & Papers

Talent Talks with Women in Governance & Boyden

Our discussion with Ray Pisani, President & CEO of Alberta Blue Cross on leadership, motivation, and the value of diversity.

Articles & Papers

Talent Talks with WXN & Boyden

Our discussion with Dr. Catherine Zahn, President & CEO of Centre for Addiction and Mental Health, on career drivers, leadership, and the diversity challenges that continue to face us today.

Articles & Papers

Talent Talks with WXN & Boyden

Our discussion with Alayne Metrick – President, St. Michael’s Hospital Foundation on leadership, diversity, team drivers and advice to the next generation.

Industry Insights

GSK’s Shift in Focus

Continuing to execute on its new R&D strategy, GlaxoSmithKline has agreed to buy the rights to a next-generation cancer immunotherapy from Merck.

Industry Insights

A Potent Combination

By merging with Celgene in a record $74 billion deal, Bristol-Meyers will create a formidable organization in the competitive immunotherapy space.

In the Media

Boyden Finds New Leader for Plasma Protein Therapeutics Association

Boyden’s Trevor Pritchard and Steve Nilsen placed Amy Efantis as new President and Chief Executive Officer of the Plasma Therapeutics Association (PPTA).

This website uses cookies to ensure you get the best experience on our website. Learn more